StockGlow

Hansa Biopharma AB (publ) (24H.F)

Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.

3.04-0.04%Healthcare
Compare 24H.F with
StockGlow Score
73
Leaning Bullish
BearishBullish
1 year ago+23.1%

The outlook

Hansa Biopharma AB (publ) currently reads as leaning bullish based on above its 50- & 200-day averages, 53% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range53% of the way from its 52-week low to high
Market cap
$303.4M
52-wk high
3.80
52-wk low
2.19
50-day avg
2.95
200-day avg
2.88
Trailing P/E
—

Similar stocks

AX9.FAkebia Therapeutics, Inc.$1.15+6.85%C4G0.F51Talk Online Education Group$14.70+3.52%88Q.F4basebio PLC$5.50+0.92%D9D.FDataproces Group A/S$0.61-3.16%B7X.FEnsurge Micropower ASA N$0.04+0.26%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy